Abstract: A vehicle 1 towing a trailer 4 is fitted with three video cameras 5, 6, 7 fitted to the rear of the vehicle and on each door mirror. A view from any camera can be presented to the driver on a display 11. A predicted trailer path, calculated in a computing unit 10, is also presented to the driver on the display 11 as guide lines overlaid on the camera view. The computing unit 10 is also configured to calculate a hitch angle by tracking the position of a trailer-mounted marker in the camera view.

Abstract: An operating table has first bed platforms, each which can rotate. In an operating configuration, the patient lies on one of the bed platforms in a prone or supine position with the bed platform centered over the base. When the patient needs to be turned, the other table extends outwardly, and both tables are rotated to position the patient for turning. Once the patient is turned, the table on which the patient lies is returned to its operating position over the base and the other table is returned to its storage position.

Abstract: With one known cable gripper device, when the gripper device contacts the outer surface of a submarine telecommunications cable, there is a problem of insufficient friction between the cable layers being acted on by the gripper, and/or insufficient adhesion between the cable layers along the cable from the gripper to the free end of the cable, and consequently there is a tendency for the protective outer sheath to be stripped from the core during recovery, with the result that the engaged end is lost. The cable grippers (100) of this invention are able to penetrate the outer protective layer and to grip the inner tensile strength core of cable.

Abstract: The present invention provides compounds of Formula (I): wherein A, B, C, G, and W1 have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Abstract: The present invention provides compounds of Formula (I): wherein A, B, C, G, and W1 have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful to treat thrombotic disorders. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula I, processes for preparing compounds of Formula I, and intermediates useful for preparing compounds of Formula I.

Abstract: A temperature controlled storage facility includes a room having an enclosed structure, and a plurality of multi-level storage zones within the room. Each of the storage zones include a supply of temperature controlled air having two outlets, one outlet positioned adjacent to a top area of the storage area, and a second outlet positioned adjacent to an aisle, wherein pressure barriers are created to prevent air flow from migrating to other storage areas or to a return duct without cooling (or heating) all of the inventory in the storage zone.

Abstract: There are provided compounds of formula (I) wherein R1 represents O, S or NH; R2 represents —C(?O)-aryl or —C(?O)-heteroaryl; R3 represents hydrogen, methyl (which may be in either the ? or ? configuration) or methylene; R4 and R5 are the same or different and each represents hydrogen or halogen; and represents a single or a double bond; and salts and solvates thereof; process for preparing them, compositions containing them and their use in therapy.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.

Abstract: (R)-5-Methyl-4,5-dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide} pharmaceutical compositions, methods and methods of using the compound or pharmaceutical compositions thereof to treat diseases characterized by abnormal thrombosis in mammals.

Abstract: The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I): and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.

Abstract: There is disclosed apparatus for directing particles entrained in a fluid, comprising a chamber having a first wall, including means for generating a sound wave having a frequency v, and a second, opposite wall capable of reflecting the sound wave in which the first and second wall define a conduit for the passage of the fluid, and in which the thickness of the second wall is such that the path length of the standing wave in the second wall is a multiple of about ½ the wavelength ?r of the sound wave therein.

Abstract: A composite constructional element 1 comprises a plank profile 2 defining a rear face 6 and two opposed edge sections 4 and 5 of the constructional element. Each edge section includes an edge face 4a,5a. A cladding material 3 is moulded into the plank profile to extend continuously between the opposed edge faces such that it is retained by the rear face and the opposed edge faces. The plank profile may further comprise retaining formations 4b,5d shaped to retain the moulded cladding material attached to the plank profile. A method of manufacturing the composite constructional element is also disclosed.

Abstract: A method, apparatus and computer program product are provided for implementing a level bias function for branch prediction control for generating test simulation vectors. User selected options are received for a set of constraints for generating test simulation vectors for branch conditional instructions. Current resource values for predicting a branch for a branch conditional instruction are read. A branch operand field is generated to include a set of valid values using the current resource values and based upon said user selected constraints. The branch operand field defines conditions under which a branch is taken.

Abstract: There are provided compounds of formula (I) wherein the variables are as defined by the present specification; and solvates thereof, processes for preparing them and their use in therapy.

Abstract: A die-level process monitor (DLPM) provides a means for independently determining whether an IC malfunction is a result of the design or the manufacturing processing and further for gathering data on specific process parameters. The DLPM senses parameter variations that result from manufacturing process drift and outputs a measure of the process parameter. The DLPM will typically sense the mismatch of process parameters between two or more test devices as a measure of process variation between a like pair of production devices. The DLPM may be used as a diagnostic tool to determine why an IC failed to perform within specification or to gather statistics on measured process parameters for a given foundry or process.

Abstract: An insect station for luring insects, baiting insects, trapping insects, monitoring insects or any combination of these functions includes a cover that can be moved to provide access to selected insect suppression devices, such as glueboards or baited pads. The insect station may have two changeable pad areas situated facing each other to provide a compact design. In addition, a base portion of the station may have a wall access opening to facilitate applying insecticide behind a wall. The insect station of the present invention may be used with any combination of attractant pads, bait, and glueboards, as well as many other insect suppression devices.

Abstract: A method and system for changing the area in which to view the content of a document while maintaining access to various viewing options. In a first state, toolbar items are displayed in a toolbar area while a document is displayed in a document area. In changing to a second viewing state, certain items of the toolbar area are hidden while a menu toolbar item remains displayed. In addition, the document area is expanded to include the now-minimized toolbar area. The menu toolbar item may become semi-transparent during the second viewing state, provides access to viewing options, and also allows the viewing state to be changed back to the first viewing state.

Abstract: A syringe device includes a first chamber defined by a cylindrical barrel, a plunger head within the barrel and a hollow needle sealed to an administering end of the barrel but open to an environment outside of the first chamber. A second chamber is defined by the barrel, the plunger head and a seal that seals around a plunger shaft leading to the plunger head and that seals an actuation end of the barrel. A receiving container having a second hollow needle attached and sealed at one end is also attached and sealed to the syringe, to thereby define a receiving chamber in fluid communication with the second chamber of the syringe and, via the second needle, with an environment outside of the receiving chamber. Depressing the plunger will infuse a substance through the first needle while simultaneously withdrawing a substance through the second needle. Reverse action is possible.

Abstract: A compound of formula (I): and pharmaceutically acceptable derivatives thereof, wherein R1 is H or C1-6alkyl; R2 is wherein defines the point of attachment of the ring; and R3 is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation of a variety of conditions and diseases.

Abstract: The invention thus provides the compounds of formula (I) and pharmaceutically acceptable salts thereof, in which: R1 and R2 are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl; R3 is selected from the group consisting of C1-6alkyl, NH2 and R5CONH; R4 is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; and R5 is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.